New Therapy Enlists Immune System To Boost Cure Rate In Childhood Cancer

Scientist have announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system. Children who received monoclonal antibodies and cytokines were 20 percent more likely to be living disease-free two years after treatment, compared to children receiving standard therapy.

Read the whole article on Science Daily

More from Science Daily